A passion to perform
shares of NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) reached at $2.22 price level during last trade its distance from 20 days simple moving average was 72.06%, and its distance from 50 days …
Top RSI Trades for the day NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) Read More
shares of Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) reached at $8.29 price level during last trade its distance from 20 days simple moving average was 38.18%, and its distance from 50 days …
ATR Oversold/Overbought Signals to Track Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) Read More
Sorrento Therapeutics, Inc. (Nasdaq: SRNE) declared publication of peer-reviewed data detailing the discovery and preclinical profiling of antibodies from the Sorrento G-MAB library with neutralizing activity against SARS-CoV-2 in vitro …
Flashy Stock: Sorrento Therapeutics, Inc. (NASDAQ:SRNE) Read More
On 05-05-2022 (Thursday), BTTX shares had a relatively better volume day versus average trading capacity of 84,246,350 shares, but with an 2.38M float and a 9.05% run over a month, …
ANALYSTS RARING HARBORS INVESTMENT: Better Therapeutics, Inc. (NASDAQ:BTTX) Is in green zone with the indicator reading 37.18% Read More
On 05-05-2022 (Thursday), SNDL shares had a relatively better volume day versus average trading capacity of 42,709,490 shares, but with an 101.71M float and a -26.01% run over a month, …
Analysts Remain Deeply Conflicted: Sundial Growers Inc. (NASDAQ:SNDL) Is in red zone with the indicator reading -4.57% Read More
On Friday, Shares of Gilead Sciences, Inc. (NASDAQ: GILD) lost -3.61% to $59.34. The stock opened its trade at $61.56 and after floating in a price range of $59.27 to …
Intraday Movers: Gilead Sciences, Inc. (NASDAQ: GILD) Read More
On Tuesday, Shares of Novartis AG (NYSE: NVS) declined -1.32% to $89.25. The stock recorded $88.96 as its minimum price and hit the max level of $91.01, during its most …
Stocks to Track: Novartis AG (NYSE: NVS) Read More
On Monday, Shares of Koninklijke Philips N.V. (NYSE: PHG) declined -11.31% to $26.91. The stock recorded $26.38 as its minimum price and hit the max level of $26.99, during its …
Trend Analysis Report: Koninklijke Philips N.V. (NYSE: PHG) Read More
On Friday, Shares of HCA Healthcare, Inc. (NYSE: HCA) declined -21.82% to $210.64. The stock recorded $209.18 as its minimum price and hit the max level of $242.00, during its …
Stocks to Track: HCA Healthcare, Inc. (NYSE: HCA) Read More
On Thursday, Shares of Gilead Sciences, Inc. (NASDAQ: GILD) rose 0.24% to $63.75. The stock recorded $63.31 as its minimum price and hit the max level of $64.28, during its …
Stocks to Track: Gilead Sciences, Inc. (NASDAQ: GILD) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Read More
On Thursday, Shares of Tilray Brands, Inc. (NASDAQ: TLRY) declined -3.14% to $5.24. The stock recorded $5.23 as its minimum price and hit the max level of $5.58, during its …
Is Tilray Brands, Inc. (NASDAQ: TLRY) A Buy after Mixed Earnings Report? Read More
On Thursday, Shares of HEXO Corp. (NASDAQ: HEXO) showed the bearish trend with a lower momentum of -6.23% and ended its trading session at $0.44. The company traded total volume …
Stocks Buzz: HEXO Corp. (NASDAQ: HEXO) Provides Update on Strategic Plan; Announces Changes to Further Streamline Operations on Path to Becoming Cash Flow Positive From Operations Read More
On Thursday, Shares of Pacific Biosciences of California, Inc. (NASDAQ: PACB) lost -4.85% to $6.67. The stock opened its trade at $7.18 and after floating in a price range of …
Watch List: Pacific Biosciences of California, Inc. (NASDAQ: PACB) transforms access to the epigenome and streamlines workflows Read More
Invitae Corporation (NYSE: NVTA), a leading medical genetics company, declared that it will report its first quarter 2022 financial results on Tuesday, May 3, 2022, and will host a conference …
Stocks in the Spotlight: Invitae Corporation (NYSE: NVTA) to Announce First Quarter 2022 Financial Results on Tuesday, May 3, 2022 Read More
On Wednesday, Shares of Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) rose 43.45% to $2.08. The stock recorded $1.7200 as its minimum price and hit the max level of $3.9400, during …
News Review: Clarus Therapeutics Holdings, Inc. (NASDAQ: CRXT) to Present New Data for JATENZO (testosterone undecanoate) at the Androgen Society 4th Annual Meeting Read More